Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiation

The increased incidence of secondary hematologic malignancies (SHM) is a well-known, potentially fatal, complication after cancer treatment. It is unknown if patients with ductal carcinoma in situ (DCIS) of the breast treated with external beam radiotherapy (RT) and who survive long-term have increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kang, Li, Zhuyue, Chen, Xingxing, Zhang, Jianjun, Xiong, Yongfu, Zhong, Guochao, Shi, Yang, Li, Qing, Zhang, Xiang, Li, Hongyuan, Xiang, Tingxiu, Foukakis, Theodoros, Radivoyevitch, Tomas, Ren, Guosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925676/
https://www.ncbi.nlm.nih.gov/pubmed/33654083
http://dx.doi.org/10.1038/s41523-021-00228-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925676/
https://www.ncbi.nlm.nih.gov/pubmed/33654083
http://dx.doi.org/10.1038/s41523-021-00228-6

Ejemplares similares